MedTrace Logo

Plaque Formation Rate and Toothpaste

NCT02697539 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 74

Last updated 2016-03-03

No results posted yet for this study

Summary

This 12-week prospective, randomized, double-blind, two-center trial evaluated the impact of a microcrystalline zinc-hydroxyapatite (mHA) dentifrice on plaque formation rate (PFR) in periodontitis patients. The investigators hypothesized that mHA precipitates cause delayed plaque development when compared to a fluoridated control (AmF/SnF2), and therefore would improve periodontal health.

Conditions

  • Chronic Periodontitis

Interventions

OTHER

AmF/SnF2

AmF/SnF2 dentifrice used twice daily for 2 minutes for 12 weeks

OTHER

mHA

microcrystalline zinc-hydroxyapatite (mHA) dentifrice dentifrice used twice daily for 2 minutes for 12 weeks.

Sponsors & Collaborators

  • Wuerzburg University Hospital

    collaborator OTHER

  • University Hospital Muenster

    lead OTHER

Principal Investigators

  • Benjamin Ehmke, Prof. Dr. · University of Münster, Department of Periodontology Waldeyerstr. 30, 48149 Münster

  • Ulrich Schlagenhauf, Prof. Dr. · University of Würzburg, Department of Periodontology Pleicherwall 2, 97070 Würzburg

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-03-31
Primary Completion
2011-09-30
Completion
2011-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02697539 on ClinicalTrials.gov